Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 6, 2021; 9(31): 9469-9480
Published online Nov 6, 2021. doi: 10.12998/wjcc.v9.i31.9469
Table 1 Distribution of exposure variables in total cohort and by faecal elastase-1 result, and result from the univariable logistic regression analysis
Variable
Total cohort, n (%)
FE1 ≥ 200 μg/g, n (%)
FE1 < 200 μg/g, n (%)
OR (95%CI)
P value
Total1027 (100)845 (82.3)182 (17.7)
Demographics
Age (yr) (mean ± SD)53.01 (17.2)52.29 (17.4)56.42 (16.0)1.01 (1.01-1.02)0.003
Sex
Male436 (42.5)343 (40.6)93 (51.1)1.53 (1.11-2.11)0.010
Ethnicity
Asian159 (15.5)116 (13.7)43 (23.6)2.02 (1.33-3.06)0.001
Black105 (10.2)85 (10.1)20 (11.0)1.28 (0.75-2.19)0.370
Other203 (19.8)171 (20.2)32 (17.6)1.02 (0.65-1.58)0.939
Comorbidities
Type 1 diabetes25 (2.4)18 (2.1)7 (3.9)1.84 (0.76-4.46)0.180
Type 2 diabetes182 (17.7)125 (14.8)57 (31.3)2.62 (1.82-3.78)< 0.001
IBD42 (4.1)36 (4.3)6 (3.3)0.77 (0.32-1.84)0.551
Liver cirrhosis57 (5.6)40 (4.7)17 (9.3)2.07 (1.15-3.74)0.016
Chronic pancreatitis48 (4.7)15 (1.8)33 (18.1)12.26 (6.50-23.12)< 0.001
Pancreatic cancer11 (1.1)4 (0.5)7 (3.9)8.41 (2.44-29.04)0.001
Previous acute pancreatitis23 (2.2)17 (2.0)6 (3.3)1.66 (0.65-4.27)0.293
Upper GI surgery49 (4.8)33 (3.9)16 (8.8)2.37 (1.27-4.40)0.006
Cholecystectomy57 (5.6)47 (5.6)10 (5.5)0.99 (0.49-1.99)0.968
Bile acid malabsorption111 (10.8)94 (11.1)17 (9.3)1.03 (0.52-2.04)0.938
Coeliac disease15 (1.5)13 (1.5)2 (1.1)0.71 (0.16-3.17)0.654
CCF13 (1.3)8 (1.0)5 (2.8)2.95 (0.95-9.13)0.060
CKD38 (3.7)25 (3.0)13 (7.1)2.52 (1.26-5.03)0.009
Hyperparathyroidism9 (0.9)8 (1.0)1 (0.6)0.58 (0.07-4.64)0.606
HIV9 (0.9)6 (0.7)3 (1.7)2.34 (0.58-9.45)0.232
Haemochromatosis3 (0.3)3 (0.4)0 (0)--
PPI therapy1425 (41.4)316 (37.4)109 (59.9)2.50 (1.78-3.52)< 0.001
Alcohol excess1
Ex-excess108 (10.5)70 (8.3)38 (20.9)3.24 (1.68-6.22)0.001
Current excess114 (11.1)87 (10.3)27 (14.8)1.83 (1.13-2.97)0.014
Smoking history1
Ex-smoker261 (25.4)207 (24.5)54 (29.7)1.55 (0.98-2.46)0.061
Current smoker176 (17.1)132 (15.6)44 (24.2)2.00 (1.31-3.04)0.001
Table 2 Distribution of symptoms in the total cohort and by faecal elastase-1 result, and results from the univariable logistic regression analysis.
Symptom
Total cohort, n (%)
FE1 ≥ 200 μg/g, n (%)
FE1 < 200 μg/g, n (%)
OR (95%CI)
P value
Abdominal pain567 (55.2)476 (56.3)91 (50.0)0.77 (0.56-1.06)0.112
Diarrhoea671 (65.3)545 (64.5)126 (69.2)1.23 (0.87-1.74)0.231
Weight loss392 (38.2)308 (36.4)84 (46.2)1.49 (1.08-2.06)0.015
Bloating263 (25.6)226 (26.7)37 (20.3)0.70 (0.47-1.03)0.072
Nausea and vomiting129 (12.6)106 (12.5)23 (12.6)1.01 (0.62-1.63)0.973
Steatorrhoea95 (9.3)64 (7.6)31 (17.0)2.51 (1.58-3.98)< 0.001
Dyspepsia86 (8.4)71 (8.4)15 (8.2)0.98 (0.55-1.75)0.943
Flatulence61 (5.9)55 (6.5)6 (3.3)0.49 (0.21-1.16)0.103
Fatigue21 (2.0)19 (2.3)2 (1.1)0.48 (0.11-2.09)0.331
Table 3 Multiple imputation multivariable logistic regression analysis showing associations between exposure variables and pancreatic exocrine insufficiency
Variable
OR (95%CI)
P value
Demographics
Age1.00 (0.99-1.01)0.597
Sex
Male1.18 (0.80-1.74)0.399
Ethnicity
Asian2.11 (1.30-3.42)0.002
Black1.22 (0.66-2.27)0.524
Other1.45 (0.88-2.38)0.144
Comorbidities
Type 2 diabetes1.84 (1.18-2.87)0.007
Liver cirrhosis0.96 (0.45-2.06)0.924
Chronic pancreatitis7.98 (3.95-16.15)< 0.001
Pancreatic cancer6.58 (1.67-25.98)0.007
Upper GI surgery2.62 (1.32-5.19)0.006
CCF1.67 (0.42-6.65)0.466
CKD1.71 (0.74-3.97)0.212
PPI1.87 (1.25-2.80)0.002
Alcohol excess
Ex-excess2.06 (0.94-4.51)0.07
Current excess1.56 (0.85-2.87)0.152
Smoking history
Ex-smoker1.02 (0.57-1.84)0.949
Current smoker1.33 (0.79-2.25)0.287